Business
Exercise of Warrants
Exercise of Warrants.
About this update from Incanthera Plc
[{"type":"text","content":"\n\n \n \n\n \n 14 August 2024\n \nIncanthera plc\n(\"Incanthera\" or the \"Company\")\nExercise of Warrants\n \nIncanthera plc (AQSE:INC), the company specially focussed on innovative technologies in dermatology and oncology, announces that it has received warrant exercise notices over 215,827 new ordinary shares in the Company, at an exercise price of 6.95 pence per share (the \"Warrant Shares\") providing the Company with proceeds of £14,999.98.\n \nAdmission\nApplication has been made for the Warrant Shares to be admitted to trading on the Aquis Stock Exchange Growth Market on or around 19 August 2024 (\"Admission\") and will rank pari passu with the ordinary shares of the Company in issue.\nTotal Voting Rights\nFollowing admission, the Company's issued share capital will be 116,896,055 ordinary shares of 2 pence each, with each share carrying the right to one vote, therefore the total number of voting rights in the Company will be 116,896,055. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.\n \n \nThe Directors of Incanthera are responsible for the contents of this announcement.\n \nThis announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).\n \nFor further information please contact:\n \n \n\n\n\n\nIncanthera plc\nwww.incanthera.com\n \nTim McCarthy, Chairman\[email protected]\n \nSimon Ward, Chief Executive Officer\[email protected]\n \nSuzanne Brocks, Head of Communications\nsuzanne.brocks@in...